Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Pain Management in Hip Fracture Surgery
NCT07905404Phase 4Not yet recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jan 2027
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by Beth Israel Deaconess Medical Center. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07905404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07905404.